As the number of elderly and high risk patients subjected to the procedure increases, the number of cardiopulmonary complications rises in parallel.3 Sedation techniques are probably responsible for some of the medical complications seen, but operator inexperience, and lack of monitoring may also be important. This audit has been designed to investigate how often problems occur at the time of upper gastrointestinal endoscopy and for a 30 day period after the procedure, and to explore common variables in endoscopy practice when such complications occur. The audit has included all flexible diagnostic and therapeutic fibreoptic upper gastrointestinal endoscopy and has excluded rigid oesophagoscopy and endoscopic retrograde cholangiopancreatography. It is hoped that the findings of this study will encourage endoscopists to examine their own practices and thus reduce complication rates associated with endoscopy.
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Methods
The project began with the researcher (MAQ) visiting all units, endoscopists, and endoscopy assistants throughout the North West region and East Anglia. For a four month period, forms completed by the endoscopist at the time of the gastroscopy recorded: where it was performed; the experience of the endoscopist; the reason for endoscopy; the nursing level; sedation and monitoring details; and the outcome. One of the important aims of the project was to assess the death and morbidity rates at the time of and for 30 days after endoscopy. When the procedures had been performed, the patients' notes were flagged requesting that any subsequent adverse events be reported to the endoscopy sister (who acted as a coordinator for the project at each site). Similarly, letters were filed in the patients' notes and sent to the patients' general practitioners explaining the purpose of the audit. All records relating to hospitals and doctors taking part in the study were strictly coded so that it would not be possible to trace any adverse outcome to an individual hospital or doctor.
Each unit was contacted on a three weekly basis to enquire about any problems with the audit including the completion of forms. The data were validated at the end of the study. Seven per cent of the completed forms were checked against the information in the hospital dosages used in both regions was wide, however, so that sole consideration of the mean doses used is unhelpful, without reference to patient age or ASA grouping. The maximum doses of diazepam and midazolam used were 50 mg and 30 mg, respectively. The variation in dose given against age shows a decrease with advancing age over 70 years (Tables I and II) but for each age group the dose given varied. A local anaesthetic spray was used much more frequently in the North West (7688% compared with 40.5%).
Most patients sedated with a combination of an opioid and a benzodiazepine were undergoing simple diagnostic rather than therapeutic endoscopy (78%, East Anglia, n=425; 58%, North West, n= 171). Although the average dose of pethidine was almost 50 mg in both regions, overall there was an increase in the mean dose of benzodiazepine given when used in combination, compared with when the benzodiazepine was used alone.
Hyoscine 22 was largely the anticholinergic of choice, though most procedures were performed without the use of hyoscine 22 or atropine. Intravenous atropine (0.6 mg) was used much more frequently in the North West (1 1*2% compared with 0. 3% in East Anglia), while conversely more endoscopists used hyoscine 22 (dose range 10-40 mg) in East Anglia (29% compared with 20.6% in the North West). Four hundred and twenty eight patients (4.2%) in the North West received flumazenil after sedation to reverse the effects of benzodiazepines compared with 20 (0.5%) in East Anglia. Whereas 22% of the doses used in East Anglia were used in an emergency to reverse benzodiazepine induced respiratory depression, the corresponding figure for the North West was 3.6%. Much of the nonurgent use of flumazenil in the North West (412 patients) reversed residual sedation when adequate staffing levels and recovery areas could not be provided.
Endoscopists differed widely in their use of continuous intravenous access, pulse oximetry, and supplementary oxygen. More inpatients than outpatients had intravenous access (59.6% and 40.2% respectively). Intravenous access was used rarely in patients who were endoscoped without sedation (5.6%). Overall, cannulas were used in 12.8% of cases and a butterfly (winged needle) in 30%; 40% of patients were endoscoped with the aid of pulse oximetry and only 12-5% were given oxygen supplementation throughout. Of particular concern are the figures relating to ASA groups 3-5 -that is, 'high risk patients': only 15% of these patients (sedated) in the North West (12.5-200 mg) . Pethidine should be given first at 25% of the dose reserved for sole administration, preferably up to 30 minutes beforehand so that the dose of benzodiazepine can be titrated carefully (again using 25% of the usual dose) once the pethidine has taken effect.8
There is now little doubt that arterial oxygen desaturation occurs frequently during upper gastrointestinal endoscopy.9"11 A fall in mean oxygen saturation to 90% or below is always significant; especially in the case of elderly patients or those with lung or heart disease. Routine oxygen supplementation'2 may help counteract, and pulse oximetry may detect the hypoxaemia associated with sedation, but these have not been shown to be standard practice in this audit. Most of the problems occurred in patients identified as high risk (ASA 3-5), but some occurred in low risk patients, so a high level of monitoring should be the rule rather than the exception.
For many endoscopists the first time they meet the patient is on the unit seconds before sedation is started and there is little time for assessment of the patient's medical condition.
In some units, despite the enthusiasm, there was a less than adequate understanding of science behind the pulse oximeter; the alarm was sometimes set at 85% or if the patients saturation was unusually low then the alarm would be set even lower! Intravenous access with an indwelling plastic cannula should be established before the procedure, and maintained until the patient has fully recovered. Most patients, however, were endoscoped without continuous intravenous access, particularly in the North West where many endoscopists favoured one injection of drugs into the ante-cubital fossa. Many in East Anglia were using butterflies, which were removed on return to the recovery area. While a butterfly permits immediate readministration of extra sedation or anticholinergic agents, if necessary, it may not remain in situ for long enough to be useful as emergency access after the procedure.13 Of the five cardiac arrests that occurred during or shortly after the procedure, four patients were endoscoped with no intravenous access. A recent report'4 prepared for the Standing Dental Advisory Committee has recommended that when intravenous agents are used an indwelling needle or cannula should be used and not removed until the patient is fully recovered; whereas the BSG has so far recommended that continuous intravenous access should be used for all 'at risk' patients. 15
ANTICHOLINERGIC AGENTS AND LOCAL

ANAESTHETICS
The use of anticholinergics during upper gastrointestinal endoscopy is decreasing. Recent reports have shown that anticholinergic premedication does not improve the quality of diagnostic endoscopy'6 nor does it have any protective effect on the heart rhythm. 17 Conversely hyoscine 22 can cause both hypotension and tachycardias. In total, eight patients experienced significant cardiac arryhthmias that required treatment, including five patients who arrested; of these, four patients had been given hyoscine 22 (two had been given doses of 40 mg). A recent study has also questioned the benefit of local anaesthetics'8; others have queried its safety margin.
Workers have shown that considerable blood concentrations have been recorded after surface anaesthesia; local anaesthetic sprayed onto a vascular membrane is absorbed as quickly as if the drug had been given intravenously. 19 Lignocaine is a respiratory depressant and it can cause hypotension, bradycardia, and cardiac arrest. These effects may be potentiated by benzodiazepines. Pharyngeal anaesthesia, combined with the presence of the fibrescope, which interferes with glottic closure and swallowing, is known to cause pulmonary aspiration20; 10 of 11 of the patients reported in the audit to have had pneumonia shortly after the procedure had received local anaesthesia (p<0.001).
RECOVERY AND FLUMAZENIL USE Most units send patients to recover for a minimum of one hour on adequately staffed and equipped bedded areas adjacent to the endoscopy room. In some hospitals the recovery area is some distance from the unit and in others, provision for recovery after endoscopy is inadequate. Units with inadequate staffing levels and too little space send patients to recover in an armchair (which may or may not recline) in rooms unstaffed save for an emergency bell, which the patient still drowsy and confused from sedation, is asked to ring if he or she requires attention. This room may be adjacent to the unit or at worse situated some yards down the corridor. As a result some units have a very low threshold for the use of flumazenil.
COMPLICATIONS, DEATHS, AND ADVERSE OUTCOMES OCCURRING WITHIN 30 DAYS OF
ENDOSCOPY
This study is the first large prospective audit of endoscopy related deaths and complications and has included events occurring up to 30 days after endoscopy. In all, 104 patients died within this period. Some died as a result of perforation, but in many other cases such as those with pneumonia, myocardial infarct, and cerebrovascular accident, the connection with endoscopy was debatable.
There were a total of five cardiac arrests either during or shortly after the procedure. Table III shows the more serious events. All were initially successfully resuscitated but one of these died four days later from an aspiration pneumonia. Cardiorespiratory complications were reported in 31 cases, many of whom required active treatment including flumazenil and oxygen therapy. As can be seen from Table III many of the patients were elderly with ASA grades 2-4 and yet intravenous access and pulse oximetry were not invariably used. Supplemental oxygen was not given to any of these patients.
The patient who developed a cerebrovascular accident immediately after the examination and died seven days later was an 82 year old man who was ASA grade 3. The dose of midazolam used (4 mg) caused both hypotension and hypoxia precipitating the cerebrovascular accident. A further five patients were reported to have developed cerebrovascular accidents at various times after gastroscopy of whom three died. In three cases the complication occurred within three days of the procedure and it is probable that the event was a direct consequence of the endoscopy. In addition to the five cardiac arrests there was a further one patient who developed chest pain, bradycardia, and an abnormal electrocardiogram suggestive of infarct. This 79 year old woman died at home seven days later but a postmortem examination was not performed. A further 18 patients had myocardial infarcts between one and 22 days after the procedure of which 13 died. As with the cerebrovascular accidents a causal link is suggested.
In total there were 1 1 cases of pneumonia, of whom eight died; two of these deaths were judged to result directly from the procedure, clearly relating to an episode of aspiration on the unit. The audit has established a clear link with local anaesthesia (p<0 00 1); 10 of 1 1 of the patients with pneumonia had been given local anaesthesia and it is probable that the other nine cases of pneumonia were related to the procedure. The use of local anaesthesia is not only implicated in causing aspiration pneumonia, but its use makes it much more probable that aspiration will go unrecognised. The eight deaths from pneumonia have been an important finding in this study and it is recommended that pneumonia complicating upper gastrointestinal endoscopy should become the focus of further study.
In a total of 36 cases of myocardial infarctions, cases of pneumonia, and cerebrovascular accidents, twice as many occurred in the first week after gastroscopy than in the second and third combined. The expected death rate from these conditions is 0068% per month21; the death rate after gastroscopy (excluding inpatients and therapeutic gastroscopy) calculated from the audit figures is 0.116% per month. Thus the observed death rate is 1.7 times higher than expected when compared with the general population for daycase diagnostic gastroscopy.
At a conservative estimate for the 13 036 patients undergoing diagnostic endoscopy without any therapeutic intervention, there was one death because of perforation, two deaths because of aspiration pneumonia, and at least one death after a cerebrovascular accident and one after myocardial infarction. A further death occurred after uncontrollable haemorrhage after biopsy of an oesophageal ulcer, and a seventh after extensive mediastinal emphysema. Thus, the death rate was estimated as at least seven of 13 036, or one in 2000. As these figures rely on the reporting of complications by anonymous doctors, they are probably an underestimate.
